Oloplit Max Eye Drops contain Olopatadine (0.7% w/v), a high-potency antihistamine ophthalmic solution formulated for intense allergic eye conditions. It provides rapid relief from severe itching, redness, and irritation, making it ideal for patients with moderate to severe allergic conjunctivitis.
Olopatadine works by blocking histamine H1 receptors, preventing the allergic response and alleviating discomfort quickly. Its advanced formulation ensures sustained relief and patient comfort, suitable for long-term management under ophthalmologist supervision.
Clinically, Oloplit Max supports once or twice daily dosing, improving patient adherence and delivering fast, reliable symptom control. Ophthalmologists often prefer this higher-strength solution for cases not adequately managed by lower concentrations.
From a business perspective, Oloplit Max Eye Drops enhance the anti-allergic ophthalmic portfolio, offering high-demand prescriptions, repeat orders, and profitable growth opportunities for PCD pharma franchise partners and distributors across India.